疟疾抗药的持续流行要求人们加紧研制新型的抗疟药。阿托喹酮是一种广谱抗原虫制剂,它通过阻止寄生虫的电位传递来阻止其裂殖繁殖,而且该药的外观易于接受。早期研究表明,单独使用阿托喹酮治疗疟疾,初期可有效控制疟原虫,但随后出现的疟原虫复发率还比较高。复发期间的疟原虫被分离出来,经阿托喹酮的单独作用后,产生 The continuing epidemic of malaria requires people to step up their efforts to develop a new type of antimalarial drug. Atorvastatin is a broad-spectrum anti-protozoal agent that prevents its fission by preventing the transmission of the parasite’s potential, and its appearance is readily acceptable. Early studies showed that treatment of malaria alone with atorvastatin effectively controlled malaria parasites in the initial period, but subsequent recurrence rates of malaria parasites were still high. Plasmodium is isolated during relapse and is produced by the action of atovalerone alone